Atilla Buyukgebiz
Overview
Explore the profile of Atilla Buyukgebiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demir A, Aydin A, Buyukgebiz A
Children (Basel)
. 2025 Jan;
12(1).
PMID: 39857924
This review examines the inconsistent effects of endocrine-disrupting chemicals (EDCs) and pollutants on pubertal timing, emphasizing the methodological challenges contributing to variability in findings. Data from nine key studies reveal...
2.
Buyukgebiz A, Demir A
Children (Basel)
. 2025 Jan;
12(1).
PMID: 39857889
Background: Recombinant growth hormone (rhGH) has been used since 1985 to treat growth hormone (GH)-induced short stature, typically associated with transient adverse events. However, lipoatrophy, characterized by irreversible damage to...
3.
Demir A, Bober E, Darcan S, Aydin A, Stenman U, Buyukgebiz A, et al.
Front Endocrinol (Lausanne)
. 2024 Jan;
14:1236710.
PMID: 38161981
Objectives: Previous studies suggest urinary luteinizing hormone (LH) and follicle-stimulating hormone (FSH) measurements by immunofluorometric assays (IFMA) as noninvasive alternatives to serum assays for puberty assessment. However, these studies excluded...
4.
Demir A, Aydin A, Buyukgebiz A
Children (Basel)
. 2023 Dec;
10(12).
PMID: 38136121
This study investigates day-to-day variations in urinary luteinizing hormone (U-LH) concentrations in children, focusing on potential minimization or correction methods. 95 children and adolescents (51 boys, 44 girls, ages 5-17)...
5.
Demir A, Buyukgebiz A, Aydin A, Hero M
Hormones (Athens)
. 2023 Nov;
23(1):151.
PMID: 38015414
No abstract available.
6.
Demir A, Buyukgebiz A, Aydin A, Hero M
Hormones (Athens)
. 2023 Nov;
23(1):141-150.
PMID: 37934386
Purpose: We explored the alternative of using overnight fold change in gonadotropin levels by comparing the last-night-voided (LNV) and first-morning-voided (FMV) urine concentrations of luteinizing hormone (LH) and follicle-stimulating hormone...
7.
Demir A, Aydin A, Buyukgebiz A, Stenman U, Hero M
J Pediatr Endocrinol Metab
. 2021 Apr;
34(7):859-866.
PMID: 33913305
Objectives: Determination of LH in urine has proved to be a reliable method for evaluation of pubertal development. The human LH assay based on time-resolved immunofluorometric (IFMA) technology (AutoDELFIA, PerkinElmer,...
8.
Atar M, Pirgon O, Buyukgebiz A
Pediatr Endocrinol Rev
. 2019 Jun;
16(4):441-451.
PMID: 31245939
Sleep disorders have been widely reported in obese individuals. Previous studies have shown that together with an increase in obesity prevalence, so does sleep duration in children and adolescents decrease....
9.
Ucar A, Abaci A, Pirgon O, Dundar B, Tutunculer F, Catli G, et al.
J Clin Res Pediatr Endocrinol
. 2018 Apr;
10(3):230-238.
PMID: 29699389
Objective: A comprehensive survey was conducted to evaluate the shortcomings of clinical care in patients with Turner syndrome (TS) in Turkey. Methods: A structured questionnaire prepared by the Turner study...
10.
Bayram Y, Gulsuner S, Guran T, Abaci A, Yesil G, Gulsuner H, et al.
J Clin Endocrinol Metab
. 2015 Mar;
100(5):E808-14.
PMID: 25774885
Context: Hypergonadotropic hypogonadism presents in females with delayed or arrested puberty, primary or secondary amenorrhea due to gonadal dysfunction, and is further characterized by elevated gonadotropins and low sex steroids....